AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588109. A total of 93 filers reported holding AVEO PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 0.17 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $1,671,000 | -44.3% | 1,978,723 | +5.5% | 0.19% | +2.2% |
| Q4 2018 | $3,000,000 | -63.0% | 1,875,000 | -23.5% | 0.18% | -65.4% |
| Q3 2018 | $8,109,000 | +19.6% | 2,449,800 | -18.3% | 0.53% | +14.8% |
| Q2 2018 | $6,780,000 | -6.5% | 3,000,000 | +20.0% | 0.46% | -28.5% |
| Q1 2018 | $7,250,000 | +3.9% | 2,500,000 | 0.0% | 0.64% | +9.0% |
| Q4 2017 | $6,975,000 | -24.0% | 2,500,000 | -0.6% | 0.59% | -39.1% |
| Q3 2017 | $9,183,000 | +23.8% | 2,515,810 | -24.7% | 0.96% | -11.7% |
| Q2 2017 | $7,419,000 | +282.2% | 3,341,750 | +1.6% | 1.09% | +261.9% |
| Q1 2017 | $1,941,000 | +259.4% | 3,290,000 | +229.0% | 0.30% | +694.7% |
| Q4 2016 | $540,000 | – | 1,000,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Greylock XI GP Limited Partnership | 584,004 | $1,068,000 | 100.00% |
| GREAT POINT PARTNERS LLC | 2,325,000 | $4,255,000 | 1.89% |
| Sarissa Capital Management LP | 2,570,759 | $4,704,000 | 1.60% |
| Deer VI & Co. LLC | 675,242 | $1,236,000 | 0.68% |
| Palo Alto Investors LP | 1,200,800 | $2,197,000 | 0.16% |
| Baupost Group | 3,829,350 | $7,008,000 | 0.11% |
| Gruss Capital Management LP | 533,253 | $976,000 | 0.05% |
| Granahan Investment Management | 676,451 | $1,238,000 | 0.04% |
| Fore Research & Management, LP | 674,200 | $1,233,000 | 0.04% |
| TFS CAPITAL LLC | 210,369 | $385,000 | 0.03% |